Maternal Phenylketonuria: Long-term Outcomes in Offspring and Post-pregnancy Maternal Characteristics
Authors:
- 1 January 2014
- book chapter
- Published by Springer Nature
- Vol. 21, 23-33
Abstract
Maternal phenylketonuria (MPKU) is a well-recognized complication of PKU and one of the most potent teratogenic syndromes of pregnancy. Virtually all offspring from untreated pregnancies in women with classic PKU have intellectual disabilities and microcephaly. Congenital heart disease and intrauterine growth retardation occur many times more often than expected in the general population. Control of maternal blood phenylalanine during pregnancy prevents most if not all of these complications. Previous studies demonstrated the benefits of treatment in terms of birth parameters and early development. In this study, physical examinations, a medical history, and neuropsychological evaluation were obtained in 47 children from 24 mothers with PKU who received treatment during pregnancy. Mothers were interviewed and administered an abbreviated IQ test. Associations between maternal factors and offspring outcomes were also analyzed. The 21 male and 26 female offspring ranged in age from 1 month to 26 years with 21 (62%) over 6 years. Results indicated mean intercanthal distances above the 70th percentile. Microcephaly was present in 19% of offspring, with head circumference below the third percentile. None of the offspring had cardiac anomalies. Mean offspring IQ was 94 ± 19, with 12% performing in the range of intellectual disability (IQ < 70). Among children >5 years of age, 25% had learning disabilities, 31% had attention deficit hyperactivity disorder (ADHD), 22% were on ADHD medication, and 34% had a diagnosis of anxiety and/or depression. Among the 24 mothers, 12 reported following the diet for PKU. Only one woman on diet had a blood phenylalanine concentration p = 0.01, CI 2.7, 16.1). On the self-report Beck Depression Inventory, Second Edition, 25% received scores indicating mild to moderate depression, and on the Beck Anxiety Inventory, 46% reported mild to moderate anxiety. Offspring IQ correlated with maternal metabolic control during pregnancy (r = 0.51), maternal IQ (r = −0.62), and socioeconomic position (r = −0.48). Offspring with ADHD, learning disabilities, or emotional disturbances were more likely to have mothers with anxiety and/or depression. To ensure optimal offspring outcomes, healthcare providers need to assess maternal nutrition, blood phenylalanine concentrations, cognitive abilities, and socioeconomic position. Interventions can then be initiated that reduce psychosocial stressors and enhance adherence to diet and positive parenting, which in turn can lead to better cognitive functioning, behavior, and emotional well-being in their children.Keywords
This publication has 32 references indexed in Scilit:
- Reaching out to the lost generation of adults with early-treated phenylketonuria (PKU)Molecular Genetics and Metabolism, 2010
- Anxiety and Anxiety Disorders in Children and Adolescents: Developmental Issues and Implications for DSM-VPsychiatric Clinics of North America, 2009
- Factors Predictive of Midlife Occupational Attainment and Psychological Functioning in Adults With Mild Intellectual DeficitsAmerican Journal on Intellectual and Developmental Disabilities, 2009
- Vitamin B12 and vitamin B6 supplementation is needed among adults with phenylketonuria (PKU)Journal of Inherited Metabolic Disease, 2006
- Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey ReplicationArchives of General Psychiatry, 2005
- TEST REVIEW Behavior Rating Inventory of Executive FunctionChild Neuropsychology, 2000
- A European Multicenter Study of Phenylalanine Hydroxylase Deficiency: Classification of 105 Mutations and a General System for Genotype-Based Prediction of Metabolic PhenotypeThe American Journal of Human Genetics, 1998
- Agoraphobia in phenylketonuriaJournal of Inherited Metabolic Disease, 1990
- New England Maternal PKU Project: Prospective study of untreated and treated pregnancies and their outcomesThe Journal of Pediatrics, 1987
- Maternal Phenylketonuria and HyperphenylalaninemiaNew England Journal of Medicine, 1980